Physician profile
Sabah Butty
NPI 1770521445
$275,219.64
in general payments reported to CMS, 2019-2025
21 companies · $94K in 2025
The $94K reported for 2025 was more than what 98% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,010 · 2020: $2,172 · 2021: $11K · 2022: $21K · 2023: $46K · 2024: $99K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $79K · Travel and Lodging: $32K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $117,537.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79,166.50 |
| Travel and Lodging | $31,887.45 |
| Food and Beverage | $10,038.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $128,267.51 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $111,408.26 | 2019-2025 | Alphavac, Angiovac, Auryon Laser System 100-120 Vac |
| Stryker Corporation | $24,322.87 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Penumbra, INC. | $7,094.14 | 2021-2025 | Indigo System, Penumbra System |
| Endovascular Engineering INC. | $1,343.10 | 2024 | Helo Thrombectomy System |
| Medtronic, INC. | $587.07 | 2021-2024 | Axium Primetm, Reliant, Solitaire X |
| Bard Peripheral Vascular, INC. | $309.09 | 2021-2024 | Rotarexs 6 F X 135 Cm, Set Aspirex S 10f 110cm |
| Cook Medical LLC | $264.93 | 2019-2022 | |
| Argon Medical Devices, INC. | $240.73 | 2024-2025 | Clot Management, Clot Management |
| Imperative Care, INC | $218.12 | 2023-2025 | Symphony Catheter, Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Philips North America LLC | $208.66 | 2020-2021 | |
| Abbott Laboratories | $155.61 | 2021-2024 | Jeti Peripheral Catheter |
| Endologix LLC | $140.59 | 2025 | Endocross Device, Torus Stent Graft System |
| Medtronic Vascular, INC. | $139.32 | 2019-2020 | |
| Terumo Medical Corporation | $118.46 | 2020-2024 | Azur Cx Detachable |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $111.71 | 2021-2025 | Angiojet Ultra 5000a |
| Biocompatibles, INC. | $110.00 | 2019 | |
| Endovascular Engineering, INC. | $80.81 | 2023 | Helo Thrombectomy System |
| Sirtex Medical INC | $54.99 | 2024-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Becton, Dickinson and Company | $29.00 | 2025 | Power-Trialysis |
| Siemens Medical Solutions USA, INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabah Butty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.